Engr-sheeza

CITI pharmaceutical

citi pharmaceutical industry limited • Período integral

May 2022 - Present • 4 yrs

Citi Pharma is a vertically integrated pharmaceutical manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and finished dosage formulations. The company operates a large, cGMP-compliant production complex with multiple segregated units to ensure quality, safety, and cross-contamination control. Its operations cover analgesics, antibiotics, and nutraceuticals, supported by an in-house quality control laboratory, modern utilities, and well-established manufacturing systems. Citi Pharma exports its products to several regional markets and continues to expand its production capacity to meet growing demand. Description of the Four Plants 1. Paracetamol Plant Dedicated facility for producing Paracetamol API in various grades. Includes controlled reaction systems, purification, drying, and dust-free packing to ensure high-purity analgesic production. 2. Penicillin / Amoxicillin Plant Segregated beta-lactam facility manufacturing Amoxicillin and related penicillin APIs. Equipped with cleanrooms, dedicated HVAC, and containment systems to prevent cross-contamination. 3. Cephalosporin Plant Independent cephalosporin unit producing APIs such as Cefixime and Cephalexin. Features advanced filtration, purification, and drying equipment with strict environmental control. 4. Ciprofloxacin / Quinolone Plant Unit focused on Ciprofloxacin and other quinolone APIs. Uses precision reactors, crystallization, drying systems, and solvent recovery to deliver consistent, high-quality products.